戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ificant differences in the severity of other abdominal symptoms.
2 ccumulate intra-abdominal fat that may cause abdominal symptoms.
3     In July, 1995, the patient had recurrent abdominal symptoms.
4 ine percent of 521 HAE attacks only involved abdominal symptoms.
5  high prevalance of long-lasting fatigue and abdominal symptoms.
6                                              Abdominal symptoms and signs may be due to SLE or due to
7 e from baseline in daily bowel habits, daily abdominal symptoms, and weekly global assessments, in ad
8             All four subjects presented with abdominal symptoms at a mean of 6.1 years posttransplant
9 ght upper quadrant symptoms, (b) generalized abdominal symptoms, (c) unexplained sepsis, or (d) sepsi
10          Neutropenic patients with fever and abdominal symptoms (cramping, pain, distention, diarrhea
11 sparaginase-associated pancreatitis, risk of abdominal symptoms dropped from 8% (26 of 312) to 0% (0
12 atients who had been using indinavir without abdominal symptoms for at least 6 months and ten HIV-1-i
13 d and sustained improvement of bowel habits, abdominal symptoms, global relief, and quality of life i
14 ed with selective liver enlargement and that abdominal symptoms in ADPKD patients may be because of e
15  linaclotide significantly reduced bowel and abdominal symptoms in patients with chronic constipation
16         Among adult patients presenting with abdominal symptoms in primary care or other unselected p
17 s variable and most patients presenting with abdominal symptoms in primary care will not have celiac
18  Fifteen patients presenting with unspecific abdominal symptoms in which food allergy was detected in
19  of linaclotide significantly improved other abdominal symptoms, including discomfort and bloating, a
20 D), a common disorder characterized by upper abdominal symptoms, including discomfort or postprandial
21 ctal bleeding (OR, 0.28; 95% CI, 0.20-0.40), abdominal symptoms (OR, 0.15; 95% CI, 0.10-0.21), or oth
22 register of Sweden, were given the validated Abdominal Symptom Questionnaire 1998-2001; 1000 of these
23 sophagogastroduodenoscopy and were given the Abdominal Symptom Questionnaire along with the Hospital
24 gn, enrolled adults presenting with nonacute abdominal symptoms, the prevalence of celiac disease was
25  in ten HIV-1-positive patients who had such abdominal symptoms to measure total adipose tissue (TAT)
26                           The performance of abdominal symptoms varied widely.
27 frequency of colorectal-cancer screening and abdominal symptoms was similar in the two groups.
28 istribution of disease, and association with abdominal symptoms were all analyzed.
29 ydrate malabsorption), flatus frequency, and abdominal symptoms were assessed after subjects ingested
30                   The most commonly reported abdominal symptoms were distension (77%), cramping (73%)
31               The presentation included mild abdominal symptoms with rapid progression of peritonitis

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。